(ON-DEMAND ACOI 2023) Update on Pulmonary Hypertension

CME Credit Available:

This activity offers 1 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Review current classification system for pulmonary hypertension (PH) with an emphasis on rare types which require specialized referral.
• Review key elements of workup which often separate pulmonary arterial hypertension from other types of PH.
• Briefly review modern approaches to therapy and risk stratification of patients with pulmonary arterial hypertension (PAH).

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Robert Schilz, DO, PhD, faculty for this activity, has disclosed the following financial relationships: 

• Honorarium - Speakers Bureau - Bayer
• Honorarium - Speakers Bureau, Consultant, Advisory Panel - Actelion J&J
• Research Support - Clinical Investigator - Acceleron
• Honorarium, Research Support - Speakers Bureau, Consultant, Advisory Panel, Clinical Investigator - United Therapeutics
• Research Support - Clinical Investigator - Bellerophon

Release & Review Date: 

This activity is valid from January 14, 2024, until January 14, 2027.